The Geometric Increase in Meta-Analyses from China in the Genomic Era
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Meta-analyses are increasingly popular. It is unknown whether this popularity is driven by specific countries and specific meta-analyses types. PubMed was used to identify meta-analyses since 1995 (last update 9/1/2012) and catalogue their types and country of origin. We focused more on meta-analyses from China (the current top producer of meta-analyses) versus the USA (top producer until recently). The annual number of meta-analyses from China increased 40-fold between 2003 and 2011 versus 2.4-fold for the USA. The growth of Chinese meta-analyses was driven by genetics (110-fold increase in 2011 versus 2003). The HuGE Navigator identified 612 meta-analyses of genetic association studies published in 2012 from China versus only 109 from the USA. We compared in-depth 50 genetic association meta-analyses from China versus 50 from USA in 2012. Meta-analyses from China almost always used only literature-based data (92%), and focused on one or two genes (94%) and variants (78%) identified with candidate gene approaches (88%), while many USA meta-analyses used genome-wide approaches and raw data. Both groups usually concluded favorably for the presence of genetic associations (80% versus 74%), but nominal significance (P<0.05) typically sufficed in the China group. Meta-analyses from China typically neglected genome-wide data, and often included candidate gene studies published in Chinese-language journals. Overall, there is an impressive rise of meta-analyses from China, particularly on genetic associations. Since most claimed candidate gene associations are likely false-positives, there is an urgent global need to incorporate genome-wide data and state-of-the art statistical inferences to avoid a flood of false-positive genetic meta-analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Self-citationLanguage bias in randomised controlled trials published in English and German
Egger, M., Zellweger-Zähner, T., Schneider, M., Junker, C., Lengeler, C., & Antes, G. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02419-7 · Cited by 1,028
Direction and impact of language bias in meta-analyses of controlled trials: empirical study
Jüni, P., Holenstein, F., Sterne, J., Bartlett, C., & Egger, M. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.115 · Cited by 892
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889 · cited 12×
“One comparison used all 100 meta-analyses; a further analysis focused only on meta-analyses that addressed only genetic variants that have not been validated in GWAS, since the large majority of these associations are likely to be spurious [8,9,10,15,16].”
BackgroundInfluentialThe False-positive to False-negative Ratio in Epidemiologic Studies
Ioannidis, J. P. A., Tarone, R., & McLaughlin, J. K. (2011) · Epidemiology · doi:10.1097/ede.0b013e31821b506e · Cited by 321 · cited 2×
“One comparison used all 100 meta-analyses; a further analysis focused only on meta-analyses that addressed only genetic variants that have not been validated in GWAS, since the large majority of these associations are likely to be spurious [8,9,10,15,16].”
BackgroundMethodSelf-citationRandomized trials published in some Chinese journals: how many are randomized?
Wu, T., Li, Y., Bian, Z., Liu, G., & Moher, D. (2009) · Trials · doi:10.1186/1745-6215-10-46 · Cited by 229
Siontis, K. C. M., Patsopoulos, N. A., & Ioannidis, J. P. A. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.26 · Cited by 117
Self-citationAre randomized trials conducted in China or India biased? A comparative empirical analysis
Zhang, D., Freemantle, N., & Cheng, K. K. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.02.010 · Cited by 51
Cited by
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses
IOANNIDIS, J. P. A. (2016) · The Milbank Quarterly · doi:10.1111/1468-0009.12210 · Cited by 1,483
Self-citationPage, M. J., Shamseer, L., Altman, D. G., Tetzlaff, J., Sampson, M., Tricco, A. C., Catalá-López, F., Li, L., Reid, E. K., Sarkis-Onofre, R., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002028 · Cited by 768
“Further, some countries, particularly China, have developed a research culture that places a strong emphasis on the production of SRs [27].”
BackgroundDavey Smith, G., Holmes, M. V., Davies, N. M., & Ebrahim, S. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00622-7 · Cited by 287
The methodological and reporting quality of systematic reviews from China and the USA are similar
Tian, J., Zhang, J., Ge, L., Yang, K., & Song, F. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.12.004 · Cited by 248
“It may be interesting to note that the current study included a total of 100 systematic reviews from each of the two countries, twice more than the number of metaanalyses (n 5 50) from each of the two countries included in a previous study [12].”
BackgroundResultInfluentialA review of recent publication trends from top publishing countries
Fontelo, P., & Liu, F. (2018) · Systematic Reviews · doi:10.1186/s13643-018-0819-1 · Cited by 186
Metadata
- Authors
- Ioannidis, J. P. A., Chang, C. Q., Lam, T. K., Schully, S. D., & Khoury, M. J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-06-12
- Volume
- 8
- Issue
- 6
- Pages
- e65602
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2102668918
- Cited by
- 62
- References
- 8
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Geometric Increase in Meta-Analyses from China in the Genomic Era. https://app.cochat.ai/papers/10.1371/journal.pone.0065602
- The paper
- Ioannidis, J. P. A., Chang, C. Q., Lam, T. K., Schully, S. D., & Khoury, M. J. (2013). The Geometric Increase in Meta-Analyses from China in the Genomic Era. PLoS ONE. https://doi.org/10.1371/journal.pone.0065602
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.